Skip to main content
. 2021 Jan 6;7(2):479–492. doi: 10.1021/acsinfecdis.0c00851

Table 2. Structural Aspects and Antitubercular Activities of Compounds P6P27.

graphic file with name id0c00851_0012.jpg

a

MIC of compound tested against Mtb H37Rv in Middlebrook 7H9/ADC/Tween.

b

MIC of compound tested against Mtb H37Rv in 7H9/glucose/casitone/tyloxapol. See the Methods section.

c

Cytotoxicity of compound tested against HepG2 cells in DMEM/10% FBS supplemented with glucose.

d

Cytotoxicity of compound tested against HepG2 cells in DMEM/10% FBS with galactose.

e

Not determined.